Personalis

About

Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine.

Menlo Park,California,United States
251 - 500
http://www.personalis.com

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: $150.10M
Industries: Biotechnology,Genetics,Health Care,Health Diagnostics
Founded date: Aug 1, 2011
Number Of Employee: 251 - 500
Operating Status: Active
Stock Symbol: nasdaq:PSNL
Legal Name: Personalis, Inc.

Personalis combines both the technology of sequencing and interpretation, with an extensive history of peer-reviewed publication and commercial success. It is providing an extensive molecular view of a patient’s tumor and characterizes its interplay with the immune system. It aids in the development of safer, effective precision cancer therapies, immunotherapies, and personalized medicines.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$359.76M

Personalis has raised a total of $359.76M in funding over 2 rounds. Their latest funding was raised on Jan 27, 2021 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jan 27, 2021	Post-IPO Equity	$150.10M	—	—	—	Detail
Jun 20, 2019	IPO	$134.66M	—	—	—	Detail
Jan 13, 2015	Series C	$33M	4	Lightspeed Venture Partners	—	Detail
Oct 7, 2013	Series B	$22M	3	Abingworth	—	Detail
Aug 15, 2011	Series A	$20M	4	—	—	Detail